aspirin has been researched along with Port-Wine Stain in 2 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Port-Wine Stain: A vascular malformation of developmental origin characterized pathologically by ectasia of superficial dermal capillaries, and clinically by persistent macular erythema. In the past, port wine stains have frequently been termed capillary hemangiomas, which they are not; unfortunately this confusing practice persists: HEMANGIOMA, CAPILLARY is neoplastic, a port-wine stain is non-neoplastic. Port-wine stains vary in color from fairly pale pink to deep red or purple and in size from a few millimeters to many centimeters in diameter. The face is the most frequently affected site and they are most often unilateral. (From Rook et al., Textbook of Dermatology, 5th ed, p483)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The patient has remained seizure-free for 23 months and demonstrated an excellent response to pulsed dye laser treatment." | 6.61 | Preventive treatment with oral sirolimus and aspirin in a newborn with severe Sturge-Weber syndrome. ( López-Gutiérrez, JC; Sánchez-Carpintero, I; Triana Junco, PE, 2019) |
| "The patient has remained seizure-free for 23 months and demonstrated an excellent response to pulsed dye laser treatment." | 2.61 | Preventive treatment with oral sirolimus and aspirin in a newborn with severe Sturge-Weber syndrome. ( López-Gutiérrez, JC; Sánchez-Carpintero, I; Triana Junco, PE, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Triana Junco, PE | 1 |
| Sánchez-Carpintero, I | 1 |
| López-Gutiérrez, JC | 1 |
| Comi, AM | 1 |
2 reviews available for aspirin and Port-Wine Stain
| Article | Year |
|---|---|
Preventive treatment with oral sirolimus and aspirin in a newborn with severe Sturge-Weber syndrome.
Topics: Administration, Oral; Aspirin; Drug Therapy, Combination; Electroencephalography; Humans; Infant, Ne | 2019 |
Presentation, diagnosis, pathophysiology, and treatment of the neurological features of Sturge-Weber syndrome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Aspirin; Brain; Diagnosis, Differential; D | 2011 |